Resultsbee.com

200 Medical Plaza Driveway Suite 22-442 MDCC,Los Angeles,CA

James D. Cherry, MD, MSc is a Distinguished Research Professor at the David Geffen School of Medicine at UCLA and UCLA Mattel Children's Hospital, Division of Infectious Diseases. Dr. Chery received his MD degree from the University of Vermont in 1957 and his MSc degree in Epidemiology from the London School of Hygiene and Tropical Medicine in 1983. He received his pediatric residency training at Boston City Hospital and Kings County Hospital and his infectious diseases fellowship training at the Thorndike Memorial Laboratory, Harvard Medical Service at Boston City Hospital. Following his infectious diseases fellowship training, Dr. Cherry established one of the first formal pediatric infectious disease fellowship programs in the world in 1963 at the University of Wisconsin. In 1973 Dr. Cherry started the first pediatric infectious training program at UCLA. During his 47 years tenure at UCLA, numerous trainees have gone on to be leaders in pediatric infectious diseases in the United States and other countries throughout the world. In 1969-70, Dr. Cherry was a visiting worker at the Medical Research Council, Common Cold Research Unit and Clinical Research Centre, Salisbury, England. From 1989 to 1996, Dr. Cherry and associates carried out an extensive pertussis vaccine efficiency trail in Erlanger, Germany. In 2000-2001, he was a visiting scholar in the Department of Clinical Veterinary Medicine, University of Cambridge, England. In addition, Dr. Cherry was the director of a vaccine reaction study in Denmark at a participant in two USAID nutrition/immunology projects in Kenya. Throughout his career, Dr. Cherry has received numerous national and international awards. Some of these include: The John and Mary B. Markle Scholar in Academic Medicine; Distinguished Physician Award of the Pediatric Infectious Diseases Society; The Stanley A. Plotkin Lectureship in Vaccinology of the Pediatric Infectious Diseases Society; The European Society for Pediatric Infectious Diseases Bill Marshall Award; The American Academy of Pediatrics Section on Infectious Diseases Award for Lifetime Contribution to Infectious Diseases Education; and The UCLA, Edward A. Dickson Emeritus Professorship Award. Dr. Cherry has published 323 research papers, 109 editorials and commentaries and 303 book chapters. He is the senior editor of Feigin and Cherry's Textbook of Pediatric Infectious Disease, which is now in its 8th edition. Dr. Cherry's laboratory experience involved virology, mycoplasmology, serology, and molecular microbiology. His main research over the last 57 years has been related to vaccines and vaccine preventable diseases (measles, rubella, influenza, smallpox, and pertussis). A major interest since 1976 relates to pertussis epidemiology and pertussis vaccines. Over the last 10 years, he and colleagues at the California Department of Public Health and California pediatric infectious diseases physicians have been studying severe pertussis in young infants. Another area of interest has been measles and measles vaccines. He and colleagues first described secondary measles vaccine failure in 1972 in Saint Louis and more recently in California. He presently is involved in measles related studies in the Democratic Republic of the Congo and in Switzerland. Finally, he has been involved in Zika virus studies in Brazil.

(131) 082 - 5522

200 Medical Plaza Driveway Suite 265,Los Angeles,CA

Grace M. Aldrovandi, MD CM, is a physician-scientist and Chief of the Division of Infectious Diseases at UCLA Mattel Children’s Hospital and a Professor of Pediatrics at the David Geffen School of Medicine of the University of California, Los Angeles. Dr. Aldrovandi is a board-certified pediatric infectious diseases specialist with over 20 years experience in caring for both general pediatric infectious diseases as well as HIV infected children and their families. Dr. Aldrovandi’s research interests include pediatric HIV, the effects of breast milk on child health and infections in immunocompromised children. She has published more than 100 peer review publications in such journals as Nature, Journal of Virology, and the New England Journal of Medicine and multiple book chapters. She has been a member of multiple National Institutes of Health study sections and lectured throughout the world. She also was invited by the National Institutes of Health (NIH) to serve as a member of the AIDS Immunology and Pathogenesis Study Section of the Center for Scientific Review. As a researcher, Dr. Aldrovandi has chaired national and international studies on HIV pathogenesis within the International Maternal, Pediatric and Adolescent AIDS Clinical Trials Network (IMPAACT) and the Adolescent Trials Network (ATN). She was elected Chair of the IMPAACT Laboratory Committee, where she provides scientific leadership and quality assurance/quality control programs for all the laboratories (Virology, Immunology, Pharmacology and Genetics). Dr. Aldrovandi was recently selected to Chair the AIDS Clinical Trials Group (ACTG) Laboratory Center in addition where she performs similar duties. She is the former Chair of the Pediatric AIDS Clinical Trials Group (PACTG) Virology Committee and a member of the phenotypic and genotypic resistance working groups as well as the dried blood spot swat team. She is also a member of the Genotypic Advisory Committee of the NIAID VQA to establish a DAIDS quality assurance program for genotypic analysis of drug resistance mutations. She has considerable scientific expertise in pediatric HIV, basic HIV virology, HIV clinical assays and HIV drug resistance. Dr. Aldrovandi has been awarded the prestigious Elizabeth Glaser Scientist Award for her work on breast milk transmission of HIV-1. More recently, Dr. Aldrovandi has investigated the role of the microbiome in normal infant development, how the microbiome is perturbed by HIV-1, and how the microbiome affects HIV-1 susceptibility at mucosal sites. Her initial interest in the microbiome developed from her studies of breast milk and breast milk transmission of HIV-1. Mother’s actively excrete bacteria and special proteins, human milk oligosaccharides, thought to support the commensal bacterial, to their infants via breast milk. Certain immune cells in the infant gut do not develop until the cells receive signals from the commensal bacteria. It is this complex interplay between mother, infant and microbe that Dr. Aldrovandi is trying to understand through many of her microbiome studies. Additionally, her investigations have expanded to improve the understanding of the microbiome in HIV susceptibility and its role in human disease and treatment response. Dr. Aldrovandi received two bachelor’s degrees and her medical degree from McGill University in Montreal, Canada. She completed an internship and residency at McGill, as well as a research fellowship in pediatric infectious diseases at the University of California, Los Angeles.

(131) 082 - 5086

201 South Lasky Drive,Beverly Hills,CA

Dr. Demetri Arnaoutakis was raised in Tampa, Florida before he was recruited to Columbia University as a Division-I athlete. He was a member of the Varsity soccer team for four years. In addition, he majored in Biological Sciences and volunteered at local New York City hospitals and homeless shelters. Following his Ivy League education from which he graduated Cum Laude, Dr. Demetri then returned home for medical school attending the University of Florida College of Medicine. As a third year medical student, he was awarded a highly competitive Doris Duke Clinical Research Fellowship. This allowed him to dedicate a year to research in head and neck cancer reconstruction at the world-renowned Johns Hopkins Hospital. Prior to graduating from medical school with Honors in Research, he was also awarded the George T. Singleton Prize for excellence in Head & Neck Surgery. He then completed a five-year residency in Otolaryngology-Head and Neck Surgery at the University of Texas Southwestern Medical Center. There, he served as Chief Resident at Parkland Memorial Hospital, one of the best and busiest facial trauma centers in the country. Recently, Dr. Demetri moved to Los Angeles for a highly coveted fellowship in Facial Plastic & Reconstructive Surgery with Dr. Andrew Frankel at the famous Lasky Clinic Surgery Center in Beverly Hills, CA. Dr. Demetri is board certified by the American Board of Otolaryngology-Head & Neck Surgery and is an active member of the American Academy of Facial Plastic and Reconstructive Surgery. He frequently travels to attend national conferences to perpetually advance his education and present his research. To date he has authored over 30 peer-reviewed publications and book chapters.

(181) 360 - 3311

100 E California Blvd,Pasadena,CA

Dr. Alasil completed his ophthalmology residency training at Yale University and joined the Retina Institute of California for his retina fellowship. Dr. Alasil was part of the team who innovated en face imaging using swept source optical coherence tomography technology in collaboration with the Massachusetts Institute of Technology. His main research interests focus on polypoidal choroidal vasculopathy, diabetic retinopathy and diabetic choroidopathy. He has written over 35 original peer-reviewed articles, major reviews,case reports, and book reviews. He has presented his work at national and international meetings including the Association of Research in Vision and Ophthalmology (ARVO) annual meeting, the American Society of Retina Specialists, and the American Academy of Ophthalmology(AAO). He won the best poster award at AAO and the ASCRS excellence in residency award. He was granted a travel grant to present his work on diabetic choroidopathy at Asia ARVO meeting in Yokohama, Japan, and he was invited to speak at the Rabb-Venable excellence in research program. He served as one of the advocacy ambassadors to the AAO midyear forum in Washington, DC.

(180) 089 - 8202

2080 Century Park E #1204,Los Angeles,CA

Dr. Bhamb is board-certified by the American Board of Orthopedic Surgery, with recent Clinical Assistant Professorships in Neurosurgery & Orthopedic Surgery at the prestigious Medical College of WI (MCW). He recently transitioned from his role as Vice Chair of Spine & Orthopedics at MCW Froedtert Pleasant Prairie Hospital to assume the position of Medical Director of Clinical Pathways at Commons Clinic, and return to SoCal. In addition to numerous published papers and book chapters, he has presented research at national meetings and received accolades including the OREF Symposium Award. He completed training at leading West Coast spine centrs with a Fellowship in Complex Spine Surgery at UC-San Francisco and residency at Cedars Sinai. Despite his exceptional pedigree, Dr. Bhamb's clients report "he treated me like I was his only patient".

(131) 043 - 7792

8916 Ashcroft Ave,West Hollywood,CA

Hilsinger-Mendelson Inc., the nation's pre-eminent bicoastal literary public relations firm, has produced an unprecedented track record of several hundred national bestsellers in the past 25 years. Orchestrating effective publicity, branding, and perennial campaigns, award-winning HMI provides prime opportunities for book and magazine publishers, authors, corporations, web-based businesses, and foundations to address their specific audiences through carefully targeted media campaigns, events, and other public relations services.

(131) 065 - 9793